FTC Finalizes Rule Extending Reporting Requirements for Pharmaceutical Patent Transfers

On 6 November 2013 the Federal Trade Commission (FTC) announced final changes to certain Hart-Scott-Rodino (HSR) rules regarding acquisitions of exclusive patent rights in the pharmaceutical industry.

Read More: FTC Finalizes Rule Extending Reporting Requirements for Pharmaceutical Patent Transfers


Download PDF Share Back To Listing
Loading data